Fate Therapeutics, Inc. (FATE)
1.835
-0.02
(-0.81%)
USD |
NASDAQ |
Nov 06, 16:00
1.83
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics EPS Diluted (TTM) : -0.782 for Sept. 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.782 |
| June 30, 2026 | -1.053 |
| March 31, 2026 | -1.090 |
| December 31, 2025 | -1.148 |
| September 30, 2025 | -1.319 |
| June 30, 2025 | -1.453 |
| March 31, 2025 | -1.492 |
| December 31, 2024 | -1.650 |
| September 30, 2024 | -1.654 |
| June 30, 2024 | -1.708 |
| March 31, 2024 | -1.917 |
| December 31, 2023 | -1.634 |
| September 30, 2023 | -1.767 |
| June 30, 2023 | -2.170 |
| March 31, 2023 | -2.421 |
| December 31, 2022 | -2.910 |
| September 30, 2022 | -3.046 |
| June 30, 2022 | -2.639 |
| March 31, 2022 | -2.437 |
| December 31, 2021 | -2.237 |
| September 30, 2021 | -2.129 |
| June 30, 2021 | -2.350 |
| March 31, 2021 | -2.12 |
| December 31, 2020 | -2.079 |
| September 30, 2020 | -1.846 |
| Date | Value |
|---|---|
| June 30, 2020 | -1.568 |
| March 31, 2020 | -1.574 |
| December 31, 2019 | -1.436 |
| September 30, 2019 | -1.310 |
| June 30, 2019 | -1.222 |
| March 31, 2019 | -1.232 |
| December 31, 2018 | -1.198 |
| September 30, 2018 | -1.240 |
| June 30, 2018 | -1.19 |
| March 31, 2018 | -1.05 |
| December 31, 2017 | -1.02 |
| September 30, 2017 | -0.94 |
| June 30, 2017 | -0.95 |
| March 31, 2017 | -1.01 |
| December 31, 2016 | -1.06 |
| September 30, 2016 | -1.11 |
| June 30, 2016 | -1.08 |
| March 31, 2016 | -1.12 |
| December 31, 2015 | -1.21 |
| September 30, 2015 | -1.25 |
| June 30, 2015 | -1.33 |
| March 31, 2015 | -1.30 |
| December 31, 2014 | -1.26 |
| September 30, 2014 | -1.25 |
| June 30, 2014 | -5.74 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AVITA Medical, Inc. | -1.444 |
| Agenus, Inc. | 0.7076 |
| Amgen, Inc. | 17.24 |
| Anika Therapeutics, Inc. | -0.1126 |
| BioCryst Pharmaceuticals, Inc. | -1.421 |